<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01436968</url>
  </required_header>
  <id_info>
    <org_study_id>PrTK03</org_study_id>
    <nct_id>NCT01436968</nct_id>
  </id_info>
  <brief_title>Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer</brief_title>
  <acronym>PrTK03</acronym>
  <official_title>A Randomized Controlled Trial of ProstAtak® as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advantagene, Inc. d.b.a. Candel Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Advantagene, Inc. d.b.a. Candel Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of ProstAtak® immunotherapy in
      combination with radiation therapy for patients with intermediate-high risk localized
      prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing
      tumor cells in an immune stimulatory environment induces the body's immune system to detect
      and destroy cancer cells. ProstAtak has shown synergy with radiation without added toxicity
      and lower than expected recurrence rates in previous clinical trials. The hypothesis is that
      ProstAtak can lead to improvement in the clinical outcome for patients with prostate cancer.
      Participants will be randomized to the ProstAtak or control arm at a 2:1 ratio. Both arms
      receive standard external beam radiation therapy. Short-term androgen deprivation therapy may
      be given but is not required.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival defined as the time from randomization until the date of the first failure event will be compared for the ProstAtak® arm versus the placebo control arm. The analyses will be based on the intent to treat population.</measure>
    <time_frame>Assessed at each visit every 6 months through year 5 until event occurs.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prostate cancer specific survival and overall survival will be compared for the ProstAtak® arm versus the placebo control arm.</measure>
    <time_frame>Assessed at each visit every 6 months through year 5 after which long-term follow up of general health status will continue yearly.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PSA nadir will be compared for the ProstAtak® arm versus the placebo control arm.</measure>
    <time_frame>Assessed at each visit every 6 months through year 5.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported Health Related Quality of Life outcomes will be collected using the Expanded Prostate Cancer Index Composite (EPIC-26) questionnaire. The change in QOL over time will be compared for the ProstAtak® arm versus the placebo control arm.</measure>
    <time_frame>Assessed at baseline and at 3, 6, 12, 18 and 24 months after completion of radiation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The safety profile will be characterized by collection of adverse event information and laboratory values during the treatment phase (until the completion of radiation). Data on late effects will be collected after radiation completion.</measure>
    <time_frame>Assessed at each visit and continuously throughout the study.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">711</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>ProstAtak®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ProstAtak® (AdV-tk) + valacyclovir + radiation therapy +/- ADT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo + valacyclovir + radiation therapy +/- ADT</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ProstAtak®(AdV-tk) + valacyclovir</intervention_name>
    <description>Patients will receive three courses of ProstAtak® each consisting of AdV-tk injection + oral valacyclovir. AdV-tk injection will be delivered to the prostate via trans-rectal ultrasound guided injection as follows:
The first injection will be given at least 15 days and not more than 8 weeks before starting radiation.
The second injection will be 0-3 days before initiation of radiation therapy.
The third injection will be 15-22 days after the 2nd injection.
The prodrug, valacyclovir, will be administered at a fixed dose for 14 days after each AdV-tk injection.
Standard external beam radiation therapy will be delivered to the prostate. Short-term androgen deprivation therapy (maximum of 6 months) is optional but must be decided before enrollment to allow for stratification.</description>
    <arm_group_label>ProstAtak®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo + valacyclovir</intervention_name>
    <description>Patients will receive three courses each consisting of placebo injection + oral valacyclovir. Placebo injection will be delivered to the prostate via trans-rectal ultrasound guided injection as follows:
The first injection will be given at least 15 days and not more than 8 weeks before starting radiation.
The second injection will be 0-3 days before initiation of radiation therapy.
The third injection will be 15-22 days after the 2nd injection.
The prodrug, valacyclovir, will be administered at a fixed dose for 14 days after each placebo injection.
Standard external beam radiation therapy will be delivered to the prostate. Short-term androgen deprivation therapy (maximum of 6 months) is optional but must be decided before enrollment to allow for stratification.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria include:

          -  Localized prostate cancer meeting the NCCN criteria of Intermediate Risk or patients
             having only one NCCN high-risk feature

               -  NCCN Intermediate Risk is defined as having at least one of the following: PSA
                  10-20 ng/ml, Gleason score =7, T2b-T2c

               -  High Risk with a single high risk feature is defined as having only one of the
                  following: PSA&gt;20 ng/ml, Gleason score 8-10, or T3a

               -  Excluded are those in the following risk groups: Low risk; High risk with more
                  than 1 high risk factor; Locally advanced/very high risk=T3b-T4; Metastatic: N1
                  or M1

          -  Planning to undergo standard prostate-only external beam radiation therapy

          -  ECOG Performance Status 0-2

        Exclusion Criteria include:

          -  Liver disease, including known cirrhosis or active hepatitis

          -  Patients on systemic corticosteroids (&gt;10mg prednisone per day) or other
             immunosuppressive drugs

          -  Known HIV+ patients

          -  Regional lymph node involvement or distant metastases

          -  Patients planning to receive whole pelvic irradiation

          -  Prior treatment for prostate cancer, except TURP or ADT. For ADT, it may only be given
             for a maximum of 6 months

          -  Patients who had or plan to have orchiectomy as the form of hormonal ablation

          -  Known sensitivity or allergic reactions to acyclovir or valacyclovir
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arizona Oncology Services Foundation</name>
      <address>
        <city>Multiple Locations</city>
        <state>Arizona</state>
        <zip>85260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Southern Arizona VA Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marivic Hansen, RN, BSN</last_name>
      <phone>520-792-1450</phone>
      <phone_ext>4122</phone_ext>
      <email>Marivic.Hansen@va.gov</email>
    </contact>
    <investigator>
      <last_name>Maximiliano Sorbellini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Northern California Health Care System</name>
      <address>
        <city>Mather</city>
        <state>California</state>
        <zip>95655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dana Nanigian, MD</last_name>
      <phone>916-366-5471</phone>
      <email>Dana.Nanigian@va.gov</email>
    </contact>
    <investigator>
      <last_name>Dana Nanigian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Precision Radiation Oncology</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Kim, MD</last_name>
      <phone>949-381-5800</phone>
      <email>paul.kim@procancercare.com</email>
    </contact>
    <investigator>
      <last_name>Paul Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley View Hospital</name>
      <address>
        <city>Glenwood Springs</city>
        <state>Colorado</state>
        <zip>81601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Page, CCRP</last_name>
      <phone>970-384-7574</phone>
      <email>Cheryl.Page@vvh.org</email>
    </contact>
    <investigator>
      <last_name>Peter J. Rossi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colorado Clinical Research</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Aggers</last_name>
      <phone>303-985-2550</phone>
      <email>Daggers@coloradouro.com</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Quinn</last_name>
      <phone>303-985-2550</phone>
      <email>Jquinn@coloradouro.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Cahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Urology</name>
      <address>
        <city>Parker</city>
        <state>Colorado</state>
        <zip>80134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sibley Memorial Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Quivers</last_name>
      <phone>202-243-2294</phone>
      <email>jquiver1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Curtiland Deville, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Mouradian, LPN</last_name>
      <phone>954-370-7555</phone>
      <email>peggy.mouradian@21co.com</email>
    </contact>
    <investigator>
      <last_name>Eric S. Chenven, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology</name>
      <address>
        <city>Lakewood Ranch</city>
        <state>Florida</state>
        <zip>34202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Richman</last_name>
      <phone>941-907-9053</phone>
      <email>kathleen.richman@21co.com</email>
    </contact>
    <investigator>
      <last_name>John Sylvester, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittney Decker, RN</last_name>
      <phone>239-430-3297</phone>
      <email>brittney.decker@21co.com</email>
    </contact>
    <investigator>
      <last_name>Chaundre K. Cross, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peggy Mouradian, LPN, CCRC</last_name>
      <phone>954-370-7555</phone>
      <email>Peggy.Mouradian@21co.com</email>
    </contact>
    <investigator>
      <last_name>Christopher T. Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Center of Florida</name>
      <address>
        <city>Pompano Beach</city>
        <state>Florida</state>
        <zip>33060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jack Herman</last_name>
      <phone>954-941-3330</phone>
      <email>Jack@floridacrc.com</email>
    </contact>
    <investigator>
      <last_name>Steven Kester, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James A. Haley Veteran's Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Baker</last_name>
      <phone>813-972-2000</phone>
      <phone_ext>6268</phone_ext>
      <email>aaron.baker3@va.gov</email>
    </contact>
    <investigator>
      <last_name>Evangelia Katsoulakis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Urology Partners</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Seibert, BS,CCRC</last_name>
      <phone>239-223-4488</phone>
      <email>linda@gulfcoastcta.com</email>
    </contact>
    <investigator>
      <last_name>Osvaldo Padron, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta VA Health Care System</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giesla Rodgers</last_name>
      <phone>404-778-5162</phone>
      <email>grodg01@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Drew Moghanaki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jesse Brown VA Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Lee, MPH</last_name>
      <phone>312-569-5973</phone>
      <email>Mary.Lee@va.gov</email>
    </contact>
    <investigator>
      <last_name>Roohollah Sharifi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fauzia Arif</last_name>
      <phone>773-702-2856</phone>
      <email>farif@radonc.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Stanley L. Liauw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Silver Cross Hospital</name>
      <address>
        <city>New Lenox</city>
        <state>Illinois</state>
        <zip>60451</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David De La Torre-dorado</last_name>
      <phone>815-300-5838</phone>
      <email>david.delatorre-dorado@uchospitals.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Golden, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southeast Louisiana Veterans Health Care System</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70119</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Camille Fournet, RN</last_name>
      <phone>504-507-2000</phone>
      <phone_ext>66065</phone_ext>
      <email>mary.fournet@va.gov</email>
    </contact>
    <investigator>
      <last_name>Louis Krane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan Silberstein, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Maryland Health Care System</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toye Jenkins</last_name>
      <phone>410-605-7000</phone>
      <phone_ext>54155</phone_ext>
      <email>toye.jenkins@va.gov</email>
    </contact>
    <investigator>
      <last_name>Mohummad M. Siddiqui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chesapeake Urology Research Associates</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omitola Odunlami</last_name>
      <phone>443-471-5749</phone>
      <email>oodunlami@chesuro.com</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Dyal</last_name>
      <phone>443-738-8188</phone>
      <email>jdyal@chesuro.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald Tutrone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Leitzel, RN</last_name>
      <phone>410-502-9242</phone>
      <email>Jvogel10@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Terry Caldwell</last_name>
      <phone>443-287-1889</phone>
      <email>caldwte@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Theodore DeWeese, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith A. Blair</last_name>
      <phone>301-319-2927</phone>
      <email>judith.R.Blair2.ctr@mail.mil</email>
    </contact>
    <contact_backup>
      <last_name>Cecile Robinson, PA-C, MPH</last_name>
      <phone>301-319-2907</phone>
      <email>cecile.robinson.ctr@mail.mil</email>
    </contact_backup>
    <investigator>
      <last_name>Inger L. Rosner, MD, MC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen R Longtine</last_name>
      <phone>508-856-6970</phone>
      <email>Karen.Longtine@umassmed.edu</email>
    </contact>
    <investigator>
      <last_name>Mitchell H. Sokoloff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas City VA Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Carlson, CCRC</last_name>
      <phone>816-861-4700</phone>
      <phone_ext>57247</phone_ext>
      <email>KARA.CARLSON@va.gov</email>
    </contact>
    <investigator>
      <last_name>Reddy Eashwer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Adult &amp; Pediatric Urology, P.C.</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Trainer, MD</last_name>
      <email>atrainer@adultpediatricuro.com</email>
    </contact>
    <contact_backup>
      <last_name>Kayla Bowles, RN</last_name>
      <phone>402-399-7823</phone>
    </contact_backup>
    <investigator>
      <last_name>Andrew Trainer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheldon Freedman MD, Ltd.</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Haney</last_name>
      <phone>702-723-0282</phone>
      <phone_ext>300</phone_ext>
      <email>ThomasHaney@Freedmanurology.com</email>
    </contact>
    <investigator>
      <last_name>Sheldon Freedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Verni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Sierra Nevada Health Care System</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barak Perahia, MD</last_name>
      <phone>775-786-7200</phone>
      <phone_ext>3400</phone_ext>
      <email>barak.perahia@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Teresa Ramirez, BN, RN</last_name>
      <phone>(775)326-2791</phone>
      <email>Teresa.Ramirez@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Barak Perahia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Urology - Cherry Hill</name>
      <address>
        <city>Cherry Hill</city>
        <state>New Jersey</state>
        <zip>08003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>New Jersey Urology - Englewood</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Blizzard</last_name>
      <phone>201-510-3178</phone>
      <email>mblizzard@njurology.com</email>
    </contact>
    <investigator>
      <last_name>Eric Margolis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glen Gejerman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Theurer Cancer Center at Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Calvanese</last_name>
      <email>beth.calvanese@hackensackmeridian.org</email>
    </contact>
    <investigator>
      <last_name>Glen Gejerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Margolis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Urology - Milburn</name>
      <address>
        <city>Millburn</city>
        <state>New Jersey</state>
        <zip>07041</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hardik Rana</last_name>
      <phone>201-510-3178</phone>
      <email>hrana@njurology.com</email>
    </contact>
    <investigator>
      <last_name>Eric Margolis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karl Coutinho, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Urology - Saddle Brook</name>
      <address>
        <city>Saddle Brook</city>
        <state>New Jersey</state>
        <zip>07663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Apolo</last_name>
      <phone>201-881-1000</phone>
      <email>aapolo@njurology.com</email>
    </contact>
    <investigator>
      <last_name>Eric Margolis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glen Gejerman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Urology - Voorhees</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>New Jersey Urology - West Orange</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hardik Rana</last_name>
      <phone>201-510-3178</phone>
      <email>hrana@njurology.com</email>
    </contact>
    <investigator>
      <last_name>Eric Margolis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karl Coutinho, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Mexico Oncology Hematology Consultants (NMOHC)</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Byatt</last_name>
      <phone>505-925-0366</phone>
      <email>lbyatt@nmcca.org</email>
    </contact>
    <investigator>
      <last_name>Gregg Franklin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Cancer Center</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Karnezis</last_name>
      <phone>505-272-5237</phone>
      <email>nkarnezis@salud.unm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mark Fischer</last_name>
      <email>mjfischer@salud.unm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas M. Schroeder, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James J. Peters VA Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Keller</last_name>
      <phone>781-584-9000</phone>
      <phone_ext>5273</phone_ext>
      <email>AlisonT.Keller@va.gov</email>
    </contact>
    <investigator>
      <last_name>Glen McWilliams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Radiation Centers of New York (Integrated Medical Professionals)</name>
      <address>
        <city>North Hills</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Primiano</last_name>
      <phone>516-394-9600</phone>
      <email>mprimiano@imppllc.com</email>
    </contact>
    <investigator>
      <last_name>Shawn H. Zimberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Associated Medical Professionals of NY, PLLC</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Faisal</last_name>
      <phone>315-558-6619</phone>
      <email>sfaisal@ampofny.com</email>
    </contact>
    <investigator>
      <last_name>Neil F. Mariados, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Durham VA Health Care System</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracey Taylor</last_name>
      <phone>919-286-0411</phone>
      <phone_ext>2746</phone_ext>
      <email>tracey.taylor18@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Jeffrey Gingrick, MD</last_name>
      <phone>919-286-0411</phone>
      <phone_ext>6939</phone_ext>
      <email>Jeffrey.Gingrich@duke.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Gingrich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati VA Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Colleen Rogge, RN</last_name>
      <email>Marycolleen.rogge@va.gov</email>
    </contact>
    <investigator>
      <last_name>Krishnanath Gaitonde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southwest Urology, Clinical Research Solutions</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Kalapis, BS</last_name>
      <phone>440-340-9010</phone>
      <email>jkalapis@crssites.com</email>
    </contact>
    <investigator>
      <last_name>Michael T Berte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Portland Health Care System</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine White</last_name>
      <phone>503-220-8262</phone>
      <phone_ext>54931</phone_ext>
      <email>Christine.White1@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Wesley Stoller</last_name>
      <phone>503-220-8262</phone>
      <phone_ext>54931</phone_ext>
      <email>Wesley.Stoller@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Garzotto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Urology Institute</name>
      <address>
        <city>Springfield</city>
        <state>Oregon</state>
        <zip>97477</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Podesta</last_name>
      <phone>514-284-5508</phone>
      <email>rpodesta@oregonurology.com</email>
    </contact>
    <contact_backup>
      <last_name>Danna Cardenas</last_name>
      <phone>514-284-5508</phone>
      <email>danna@oregonurology.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bryan Mehlhaff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MidLantic Urology</name>
      <address>
        <city>Bala-Cynwyd</city>
        <state>Pennsylvania</state>
        <zip>19004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Zinar</last_name>
      <phone>610-667-3020</phone>
      <email>czinar@ucsepa.com</email>
    </contact>
    <investigator>
      <last_name>Laurence Belkoff, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lancaster Urology</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Stern</last_name>
      <phone>717-393-1771</phone>
      <phone_ext>4544</phone_ext>
      <email>dawns@lancuro.com</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Nonnemacher</last_name>
      <phone>717-393-1771</phone>
      <phone_ext>4544</phone_ext>
      <email>jennifern@lancuro.com</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Sieber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leanne Schimke</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111-2497</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital, Allegheny Health Network</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Triangle Urological Group, Allegheny Health Network</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Wexford Health and Wellness Pavilion, Cancer Institute</name>
      <address>
        <city>Wexford</city>
        <state>Pennsylvania</state>
        <zip>15090</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Ralph H. Johnson Veterans Affairs Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Caulder, RN, MSN, CCRC</last_name>
      <phone>843-789-7816</phone>
      <email>Susan.caulder@va.gov</email>
    </contact>
    <investigator>
      <last_name>Stephen J. Savage, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Urologic Research Center, LLC</name>
      <address>
        <city>Myrtle Beach</city>
        <state>South Carolina</state>
        <zip>29572</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal Shore, MD</last_name>
      <phone>843-449-1010</phone>
      <email>nshore@auclinics.com</email>
    </contact>
    <investigator>
      <last_name>Neal Shore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Urology Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karina Garcia</last_name>
      <phone>512-349-9889</phone>
      <phone_ext>105</phone_ext>
      <email>karina@driresearchsite.com</email>
    </contact>
    <contact_backup>
      <last_name>Hadie Mendoza</last_name>
      <phone>512-349-9889</phone>
      <phone_ext>103</phone_ext>
      <email>hadie@driresearchsite.com</email>
    </contact_backup>
    <investigator>
      <last_name>Koushik Shaw, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA North Texas Health Care System</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elonm Gbedey</last_name>
      <phone>214-857-0662</phone>
      <email>Elonm.Gbedey@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Ayesha Fonseca</last_name>
      <phone>214-857-1013</phone>
      <email>ayesha.fonseca@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Manoj Reddy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Urology Clinics of North Texas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Dr. Irving Fishman's Office</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Houston Willowbrook Radiation Oncology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77070</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maegan Glass</last_name>
      <phone>281-351-5174</phone>
      <email>Maegan.Glass@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Abhilasha Patel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Ned Stein's Office</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>South Texas San Antonio VA Healthcare System</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229-4404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alex Aguilera</last_name>
      <phone>210-617-5300</phone>
      <phone_ext>13264</phone_ext>
      <email>alexander.aguilera@va.gov</email>
    </contact>
    <investigator>
      <last_name>Michael Liss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Jones, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Wheeler</last_name>
      <phone>210-567-1172</phone>
      <email>WheelerA2@uthscsa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michael Liss</last_name>
      <email>Liss@uthscsa.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Liss</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Urology Specialists-The Woodlands</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77385</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maegan Glass</last_name>
      <phone>281-351-5174</phone>
      <email>maegan.glass@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Steven W. Sukin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital - The Woodlands</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77385</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maegan Glass</last_name>
      <phone>281-351-5174</phone>
      <email>Maegan.Glass@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Steven W Sukin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Urology Specialists</name>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maegan Glass</last_name>
      <phone>281-351-5174</phone>
      <email>Maegan.Glass@usoncology.com</email>
    </contact>
    <investigator>
      <last_name>Steven W. Sukin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Potomac Urology Center</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nilay Gandhi, MD</last_name>
      <email>ngandhi@potomacurology.com</email>
    </contact>
    <contact_backup>
      <last_name>Morgan Bowlen</last_name>
      <email>mbowlen@potomacurology.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nilay Gandhi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanie Eason</last_name>
      <phone>804-675-6731</phone>
      <email>jeanie.eason@va.gov</email>
    </contact>
    <investigator>
      <last_name>Michael Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Salem VA Medical Center</name>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <zip>24153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris L. Angiletta</last_name>
      <phone>540-982-2463</phone>
      <phone_ext>4060</phone_ext>
      <email>Christopher.angiletta@va.gov</email>
    </contact>
    <investigator>
      <last_name>Edgar Castillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Urology of Virginia, PLLC</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Ann Brand, RN</last_name>
      <phone>757-452-3464</phone>
      <email>lbrand@urologyofva.net</email>
    </contact>
    <investigator>
      <last_name>Robert Given, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MultiCare Regional Cancer Center - Gig Harbor</name>
      <address>
        <city>Gig Harbor</city>
        <state>Washington</state>
        <zip>98335</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Macon</last_name>
      <phone>253-403-0791</phone>
      <email>smmacon@multicare.org</email>
    </contact>
    <investigator>
      <last_name>Jennifer Slim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MultiCare Regional Cancer Center - Tacoma</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Macon</last_name>
      <phone>253-403-0791</phone>
      <email>smmacon@multicare.org</email>
    </contact>
    <investigator>
      <last_name>Jennifer Slim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Caribbean Healthcare System</name>
      <address>
        <city>San Juan</city>
        <zip>00921</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa Rivera-Gonzalez</last_name>
      <phone>787-641-7582</phone>
      <phone_ext>10483</phone_ext>
      <email>vanessa.rivera-gonzalez@va.gov</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Perazza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Puerto Rico</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 19, 2011</study_first_submitted>
  <study_first_submitted_qc>September 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2011</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Valacyclovir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

